CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
Revenues	$ 158,917	$ 122,651	$ 444,065	$ 334,184
Transaction costs ($384 and $942 interest expense and fees associated with related party transaction during the three and nine months ended September 30, 2022, respectively; refer to Notes 6 and 14 for further information)	27,986	24,670	79,773	73,346
Other operating expenses	37,744	34,402	107,895	93,026
Research and development expenses	29,617	20,104	82,139	55,298
Sales and marketing expenses	41,081	29,589	112,370	80,430
General and administrative expenses	21,693	15,957	60,013	44,637
Depreciation and amortization	5,899	4,435	15,525	13,463
Total operating expenses	164,020	129,157	457,715	360,200
Operating loss	(5,103)	(6,506)	(13,650)	(26,016)
Financial income (expense):
Gain (loss) from change in fair value of Warrants	(15,095)	11,321	28,932	23,397
Other financial expense, net	(3,617)	(3,306)	(11,136)	(6,865)
Financial income (expense), net	(18,712)	8,015	17,796	16,532
Income (loss) before taxes on income and share of gain (loss) of associated company	(23,815)	1,509	4,146	(9,484)
Taxes on income	2,635	662	5,976	5,590
Share in gain (loss) of associated company	(2)	(10)	11	(11)
Net income (loss)	$ (26,452)	$ 837	$ (1,819)	$ (15,085)
Per share data
Net income (loss) per share attributable to common stockholders - Basic earnings (loss) per share	$ (0.08)		$ (0.01)	$ (0.31)
Diluted earnings (loss) per share	$ (0.08)		$ (0.01)	$ (0.31)
Weighted average common shares outstanding - Basic	349,740,787	339,715,405	345,359,986	156,915,380
Weighted average common shares outstanding - Diluted	349,740,787	374,395,385	345,359,986	156,915,380